Results 21 to 30 of about 13,451 (203)
Frontiers in Pharmacology, 2022 Objective: Cefoperazone/sulbactam is a commonly used antibiotic combination against the extended-spectrum beta-lactamases (ESBLs)-producing bacteria. The objective of this study was to evaluate the efficacy of a new cefoperazone/sulbactam combination (3 ...
Xi-Wei Ji +10 more
doaj +1 more source
RATIONAL USE OF 3rd GENERATION CEPHALOSPORINS IN TERTIARY CARE HOSPITALS: A CONCURRENT DUR
International Journal of Pharmacy & Integrated Health Sciences, 2022 Background: Assessment of use of antimicrobials can be performed by evaluating their use. Drug use evaluation is a performance improvement method that concentrates on improvement and evaluation of drug use processes to achieve optimal patient outcomes.
doaj +1 more source
Antibiotics, 2022 Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with hospital ...
Yingjie Zhou +9 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2021 The last decade has witnessed a massive increase in the rate of mortalities caused by multidrug-resistant Pseudomonas aeruginosa. Therefore, developing new strategies to control virulence factors and pathogenicity has received much attention.
Nourhan G. Naga +4 more
doaj +1 more source
Cefoperazone metal complexes and their antimicrobial investigations
Journal of the Turkish Chemical Society, Section A: Chemistry, 2021 Transition metal (Cd(II), Co(II), Cu(II), Fe(III), Ni(II), Pd(II), Pt(II), Ru(III), Zn(II)) complexes of cefoperazone (CFP) were synthesized and their spectroscopic (IR, UV-Vis), magnetic, thermal (DTA-TG) and mass investigations were conducted to ...
Mehmet Emin ÇINAR +2 more
doaj +1 more source
Economic Examination of Cefoperazone Therapy [PDF]
, 1987 Medical records of 1137 patients from 35 hospitals were reviewed to examine the total cost of care for patients receiving cefoperazone as initial therapy compared to a control group receiving alternative agents.
Susan Wyant, Jake Jacobs
core +1 more source
Antimicrobial Resistance and Infection Control, 2019 Background We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI).
Tianshui Niu +5 more
doaj +1 more source
Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review
Journal of International Medical Research, 2021 Eosinophilic peritonitis (EP) is a well-described complication of peritoneal dialysis that occurs because of an overreaction to constituents that are related to the catheter or tubing, peritoneal dialysate, pathogenic infection, or intraperitoneal drug ...
Zi Wang +6 more
doaj +1 more source
In vitro evaluation of cefoperazone [PDF]
Antimicrobial Agents and Chemotherapy, 1980 The activity of cefoperazone, a new broad-spectrum cephalosporin, was tested in vitro against 670 clinical isolates of gram-negative bacilli and gram-positive cocci. With the exception of Enterobacter spp., it inhibited the majority of all organisms tested at a concentration of 6.25 microgram/ml.
A M, Hinkle, B M, LeBlanc, G P, Bodey
openaire +2 more sources
Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep [PDF]
, 1985 Guerrini, V.H., Filippich, L.J., Cao, G.R., English, P.B. & Bourne, D.W.A. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep. J. vet. Pharmacol. Therap. 8, 120–127.
CAO, G. R. +9 more
core +1 more source